Author/Authors :
Naoaki Fujii، نويسنده , , Jose J. Haresco، نويسنده , , Kathleen A.P. Novak، نويسنده , , Robert M. Gage، نويسنده , , Nicoletta Pedemonte، نويسنده , , David Stokoe، نويسنده , , Irwin D. Kuntz، نويسنده , , R. Kiplin Guy، نويسنده ,
Abstract :
Novel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain. Iterative molecular docking and modeling allowed the design of an indole scaffold 10a as a reversible inhibitor of ligand binding. The 10a scaffold inhibited the interaction between MAGI-3 and PTEN and showed cellular activities that are consistent with the inhibition of NHERF-1 function.
Keywords :
PDZ domain , NHERF , Protein–protein , interaction , Drug design